Research Catalog

Tumor progression and therapeutic resistance

Title
Tumor progression and therapeutic resistance / edited by Wafik S. El-Deiry.
Publication
New York, N.Y. : New York Academy of Sciences, 2005.

Available Online

Table of contents

Items in the Library & Off-site

Filter by

1 Item

StatusFormatAccessCall NumberItem Location
TextRequest in advance JSE 06-569Offsite

Details

Additional Authors
El-Deiry, Wafik S.
Description
xi, 198 p. : ill.; 24 cm.
Series Statement
Annals of the New York Academy of Sciences ; v. 1059
Subject
  • Cancer invasiveness > Congresses
  • Metastasis > Congresses
  • Drug resistance in cancer cells > Congresses
  • Cancer cells > Congresses
  • Cell transformation > Congresses
Note
  • This volume is the result of an international conference, held on November 8-9, 2004, in Philadelphia, Pennsylvania.
Bibliography (note)
  • Includes bibliographical references and index.
Contents
Proteomics in tumor progression and metastasis / Patrick A. Everley and Bruces R. Zetter -- Cytoplasmic/nuclear shuttling and tumor progression / Shao-Chun Wang and Mien-Chie Hung -- Targeting intracellular signaling pathways as a novel strategy in melanoma therapeutics / Keiran S.M. Smalley and Meenhard Herlyn -- Studies into the anticancer effects of selenomethionine against human colon cancer / Mark A. Nelson ... [et al.] -- Mechanisms of prostate tumorigenesis: roles for transcription factors Nkx3.1 and Egr1 / Sarki A. Abdulkadir -- Sulindac sulfone is most effective in modulating (beta)-catenin-mediated transcription in cells with mutant APC / Wen-Chi L. Chang ... [et al.] -- Targeting ligand cleavage to inhibit the ErbB pathway in cancer / Bin-Bing S. Zhou -- Preclinical modeling of combination treatments: fantasy or requirement? / Shannon Decker and Edward A. Sausville -- Mechanisms of trastuzumab resistance and their clinical implications / Keng-Hsueh Lan, Chien-Hsing Lu, and Dihua Yu -- Regulation of cancer cell survival by Par-4 / Padhma Ranganathan and Vivek M. Rangnekar -- Morphogenics as a tool for target discovery and drug development / Nicholas C. Nicolaides ... [et al.] -- A comprehensive strategy to combat colon cancer targeting the adenomatous polyposis coli tumor suppressor gene / Eugene W. Gerner ... [et al.] -- External imaging of CCND1, MYC, and KRAS oncogene mRNAs with tumor-targeted radionuclide-PNA-peptide chimeras / Xiaobing Tian ... [et al.] -- Functional validation of genes implicated in lymphoma genesis: in vivo selection assay using a MYC-induced B cell tumor / Duonan Yu ... [et al.] -- The proteasome inhibitor bortezomib (velcade) sensitizes some human tumor cells to Apo2L/TRAIL-mediated apoptosis / Alan D. Brooks ... [et al.] -- The role of tuberin in cellular differentiation: are B-Raf and MAPK involved? / Magdalena Karbowniczek and Elizabeth Petri Henske -- A role for Hath1, a bHLH transcription factor, in colon adenocarcinoma / Ching Ching Leow, Paul Polakis, and Wei-Qiang Gao.
Call Number
JSE 06-569
ISBN
  • 1573315435 (cloth : alk. paper)
  • 1573315443 (pbk. : alk. paper)
LCCN
2005029003
OCLC
61860836
Title
Tumor progression and therapeutic resistance / edited by Wafik S. El-Deiry.
Imprint
New York, N.Y. : New York Academy of Sciences, 2005.
Series
Annals of the New York Academy of Sciences ; v. 1059
Bibliography
Includes bibliographical references and index.
Connect to:
Table of contents
Added Author
El-Deiry, Wafik S.
Research Call Number
JSE 06-569
View in Legacy Catalog